This medicinal product must not be used in the following cases: Pre-exposure: Severe febrile infection, acute disease, progressive chronic disease (it is preferable to postpone vaccination).
Known hypersensitivity to any of the ingredients of the vaccine, to polymyxin B, to streptomycin, to neomycin or to any antibiotic of the same group, to a previous administration or to any vaccine containing the same components.
Post-exposure: Due to the fatal progression of declared rabies infection, there are no contraindications to curative vaccination.
Pregnancy: see Use in Pregnancy & Lactation.
Other Services
Country
Account